Our top pick for
Building a portfolio
INVO Bioscience, Inc is a medical devices business based in the US. INVO Bioscience shares (INVO) are listed on the NASDAQ and all prices are listed in US Dollars. INVO Bioscience employs 5 staff and has a trailing 12-month revenue of around USD$1.2 million.
|52-week range||USD$2.8 - USD$8|
|50-day moving average||USD$4.0614|
|200-day moving average||USD$3.8473|
|Wall St. target price||USD$5.88|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Revenue TTM||USD$1.2 million|
|Gross profit TTM||USD$1.3 million|
|Return on assets TTM||-128.54%|
|Return on equity TTM||0%|
|Market capitalisation||USD$43.9 million|
TTM: trailing 12 months
There are currently 16,770 INVO Bioscience shares held short by investors – that's known as INVO Bioscience's "short interest". This figure is 15.6% down from 19,865 last month.
There are a few different ways that this level of interest in shorting INVO Bioscience shares can be evaluated.
INVO Bioscience's "short interest ratio" (SIR) is the quantity of INVO Bioscience shares currently shorted divided by the average quantity of INVO Bioscience shares traded daily (recently around 129000). INVO Bioscience's SIR currently stands at 0.13. In other words for every 100,000 INVO Bioscience shares traded daily on the market, roughly 130 shares are currently held short.
To gain some more context, you can compare INVO Bioscience's short interest ratio against those of similar companies.
However INVO Bioscience's short interest can also be evaluated against the total number of INVO Bioscience shares, or, against the total number of tradable INVO Bioscience shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case INVO Bioscience's short interest could be expressed as 0% of the outstanding shares (for every 100,000 INVO Bioscience shares in existence, roughly 0 shares are currently held short) or 0.0018% of the tradable shares (for every 100,000 tradable INVO Bioscience shares, roughly 2 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against INVO Bioscience.
Find out more about how you can short INVO Bioscience stock.
We're not expecting INVO Bioscience to pay a dividend over the next 12 months.
You may also wish to consider:
INVO Bioscience's shares were split on a 5:8 basis on 8 November 2020. So if you had owned 8 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your INVO Bioscience shares – just the quantity. However, indirectly, the new 60% higher share price could have impacted the market appetite for INVO Bioscience shares which in turn could have impacted INVO Bioscience's share price.
Over the last 12 months, INVO Bioscience's shares have ranged in value from as little as $2.8 up to $8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while INVO Bioscience's is -1.3288. This would suggest that INVO Bioscience's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, INVO Bioscience has bucked the trend.
To put INVO Bioscience's beta into context you can compare it against those of similar companies.
INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. The company offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development; and INVOcell Retention device, a single-use modified diaphragm that includes holes to allow for natural drainage of vaginal fluids to aid in retention of the INVOcell device in the vaginal cavity during the incubation period. It also provides fixed laboratory equipment comprising microscopes with video systems, bench centrifuges, incubators without CO2, bench warmers, and laminar flow hoods. The company sells its products to physicians and IVF centers. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Massachusetts.
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.